Recombinant ITGA4, ITGB7 (Etrolizumab Biosimilar) antibody
Quick Overview for Recombinant ITGA4, ITGB7 (Etrolizumab Biosimilar) antibody (ABIN7597677)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Etrolizumab Biosimilar Antibody
-
Specificity
- ITGA4, CD49d, CD49 antigen-like family member D, CD49D, VLA-4 subunit alpha, Integrin alpha-IV, Integrin alpha-4, Gut homing receptor beta subunit, Integrin beta-7, ITGB7
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- ITGA4, ITGB7 (Etrolizumab Biosimilar)
-
Alternative Name
- Etrolizumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- ITGA4, CD49d, CD49 antigen-like family member D, CD49D, VLA-4 subunit alpha, Integrin alpha-IV, Integrin alpha-4, Gut homing receptor beta subunit, Integrin beta-7, ITGB7
-
UniProt
- P13612, P26010
-
CAS-No
- 1044758-60-2
Target
-